Raludotatug Deruxtecan (R-DXd) is a medication being studied for its potential to treat advanced or metastatic solid tumors. This means it is being tested to see if it can help shrink or control tumors that have spread to other parts of the body. The trial is looking at how well this medication works in different types of cancer and how safe it is for patients to use. The goal is to see if it can improve the condition of patients with these serious types of cancer. The medication is given to patients, and researchers are closely monitoring how their tumors respond and any side effects they might experience.

Endometrial Cancer – Endometrial cancer originates in the lining of the uterus, known as the endometrium. It typically begins with abnormal cell growth in this lining, which can form a tumor. As the disease progresses, the cancerous cells may invade deeper layers of the uterus and potentially spread to nearby organs. Over time, it can metastasize to distant parts of the body, such as the lungs or liver. The progression is often marked by symptoms like unusual vaginal bleeding or discharge.

Cervical Cancer – Cervical cancer starts in the cells of the cervix, the lower part of the uterus that connects to the vagina. It usually develops slowly, beginning with precancerous changes that can be detected through screening. If untreated, these changes can progress to invasive cancer, spreading into the deeper tissues of the cervix and nearby areas. Advanced stages may involve the spread to distant organs. Symptoms often include irregular bleeding, pelvic pain, or pain during intercourse.

Non-High-Grade Serous Ovarian Cancer – This type of ovarian cancer arises from the cells on the surface of the ovary. It is characterized by slower growth compared to high-grade serous ovarian cancer. The disease may initially be confined to the ovaries but can spread to the pelvis and abdomen. As it progresses, it can affect other organs, leading to symptoms like abdominal bloating, pain, and changes in bowel habits.

Urothelial Cancer – Urothelial cancer, also known as transitional cell carcinoma, primarily affects the bladder but can also occur in the ureters and renal pelvis. It begins in the urothelial cells lining these organs. The disease can progress from superficial layers to deeper muscle layers and potentially spread to other parts of the body. Symptoms often include blood in the urine, frequent urination, and pain during urination.

Clear Cell Renal Cell Carcinoma (ccRCC) – Clear cell renal cell carcinoma is a type of kidney cancer that originates in the renal cortex. It is characterized by the presence of clear cells when viewed under a microscope. The disease can grow into a large mass within the kidney and may invade nearby tissues or spread to distant organs. Symptoms may include blood in the urine, flank pain, and a palpable mass in the abdomen.